PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV)

[1]  T. Suhara,et al.  Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. , 2010, Brain : a journal of neurology.

[2]  A. Aliaga,et al.  Imaging of cholinergic terminals in the non-human primate brain using 18F-FEOBV PET: Development of a tool to assess cholinergic losses in Alzheimer's disease , 2010, Alzheimer's & Dementia.

[3]  A. Köfalvi,et al.  Modification upon aging of the density of presynaptic modulation systems in the hippocampus , 2009, Neurobiology of Aging.

[4]  R. Koeppe,et al.  Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter. , 2009, Nuclear medicine and biology.

[5]  M. Cruz,et al.  The length of hippocampal cholinergic fibers is reduced in the aging brain , 2008, Neurobiology of Aging.

[6]  E. Mufson,et al.  Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications , 2008, Expert review of neurotherapeutics.

[7]  Michèle Allard,et al.  In vivo SPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease , 2008, NeuroImage.

[8]  M. Fulham,et al.  Ex vivo and in vivo evaluation of (2R,3R)‐5‐[18F]‐fluoroethoxy‐ and fluoropropoxy‐benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter , 2007, Synapse.

[9]  M. Ward,et al.  Biomarkers for Alzheimer’s disease , 2007, Expert review of molecular diagnostics.

[10]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  K. Davis,et al.  Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease , 2006, Neurology.

[12]  Eric M Reiman,et al.  The Role of Biomarkers in Clinical Trials for Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[13]  D. D. Matsievskii,et al.  Role of Cholinergic Structures in Individual Resistance of Rat Circulatory System to Posthemorrhagic Hypoxia , 2005, Bulletin of Experimental Biology and Medicine.

[14]  Simon R. Cherry,et al.  Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain , 2003, NeuroImage.

[15]  Richard E Carson,et al.  In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers , 2003, Synapse.

[16]  L. Thal,et al.  Mnemonic Deficits in Animals Depend upon the Degree of Cholinergic Deficit and Task Complexity , 2002, Experimental Neurology.

[17]  B. Bontempi,et al.  Selective immunolesioning of the basal forebrain cholinergic neurons in rats: effect on attention using the 5-choice serial reaction time task , 2002, Psychopharmacology.

[18]  S. Efange.  In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  N. Volkow,et al.  Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  G. Halliday,et al.  Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. , 2000, Brain : a journal of neurology.

[21]  L. Thal,et al.  Intraparenchymal infusions of 192 IgG-saporin: development of a method for selective and discrete lesioning of cholinergic basal forebrain nuclei , 1999, Journal of Neuroscience Methods.

[22]  D. Kuhl,et al.  [18F]fluoroethoxy‐benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses , 1998, Synapse.

[23]  K. Ajiki,et al.  Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry , 1997, Journal of Chemical Neuroanatomy.

[24]  M. Schäfer,et al.  Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Yi,et al.  Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  J. Hauw,et al.  Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease , 1995, Neurobiology of Aging.

[27]  S. L. Mobley,et al.  Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  R. Quirion,et al.  Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. , 1993, Journal of psychiatry & neuroscience : JPN.

[29]  D. Kuhl,et al.  Synthesis of [18F]fluoroethoxy-benzovesamicol, a radiotracer for cholinergic neurons , 1993 .

[30]  C. Geula,et al.  Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus , 1992, The Journal of comparative neurology.

[31]  E. Friedman,et al.  Pre- and post-synaptic cholinergic dysfunction in aged rodent brain regions: New findings and an interpretative review , 1990, International Journal of Developmental Neuroscience.

[32]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  M M Mesulam,et al.  Human reticular formation: Cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons , 1989, The Journal of comparative neurology.

[34]  C. Geula,et al.  Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase , 1988, The Journal of comparative neurology.

[35]  A. Levey,et al.  Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey , 1983, The Journal of comparative neurology.

[36]  F. Foti,et al.  Effects of chronic donepezil treatment and cholinergic deafferentation on parietal pyramidal neuron morphology. , 2009, Journal of Alzheimer's disease : JAD.

[37]  M. Schäfer,et al.  Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat , 2007, Journal of Molecular Neuroscience.

[38]  T. Durkin,et al.  Cholinergic neurotransmission in the central nervous system of the snell dwarf mouse , 1985, Journal of neuroscience research.

[39]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .